These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 949026)

  • 1. Antiarrhythmic activity of potassium canrenoate in man.
    Yeh BK; Chiang BN; Sung PK
    Am Heart J; 1976 Sep; 92(3):308-14. PubMed ID: 949026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potassium canrenoate in the treatment of long-term digoxin-induced arrhythmias in conscious dogs.
    deGuzman NT; Yeh BK
    Am J Cardiol; 1975 Mar; 35(3):413-20. PubMed ID: 1114999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of intravenous potassium canrenoate in patients with severe heart failure and digitalis toxicity.
    Cristodorescu R; Puschita M; Deutsch G; Berger E; Luca C
    Med Interne; 1977; 15(1):27-34. PubMed ID: 841250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the aldosterone antagonist, canrenoate potassium for treating chronic circulatory insufficiency].
    Sidorenko BA; Kudisov IuM; Rossel's AN; Razumova ET
    Kardiologiia; 1979 Mar; 19(3):41-6. PubMed ID: 372667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Canrenoate--a spironolactone metabolite. Acute cardiac effects in digitalized patients.
    Waldorff S; Buch J
    Eur J Cardiol; 1979 Aug; 10(2):143-9. PubMed ID: 477703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.
    Yeh BK; Sung PK; Lazzara R
    Clin Pharmacol Ther; 1974 Dec; 16(6):1014-22. PubMed ID: 4433469
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of digitalis toxicity with intravenous potassium canrenoate.
    Gavrilescu G; Cristodorescu R; Deutsch G; Berger E
    Agressologie; 1977; 18(3):167-71. PubMed ID: 920909
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cardiac effects of antikaliuretic diuretics-clinical and biochemical investigation (author's transl)].
    Erdmann E; Krawietz W; Poppert D; Krüger R; von Arnim T; Vogt W; Bolte HD
    Klin Wochenschr; 1977 Oct; 55(20):985-94. PubMed ID: 144825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disappearance of spironolactone-induced gynaecomastia during treatment with potassium canrenoate.
    Dupont A
    Lancet; 1985 Sep; 2(8457):731. PubMed ID: 2863716
    [No Abstract]   [Full Text] [Related]  

  • 10. [Life-threatening digitalis intoxication with and without additional diuretic treatment (author's transl)].
    Lehmann HU; Witt E; Temmen L; Hochrein H
    Dtsch Med Wochenschr; 1978 Oct; 103(40):1566-71. PubMed ID: 81123
    [No Abstract]   [Full Text] [Related]  

  • 11. Canrenoate reversal of inhibitory effects of digoxin on basal and furosemide-stimulated renin secretion.
    Finotti P; Antonello A
    Clin Pharmacol Ther; 1982 Jul; 32(1):1-6. PubMed ID: 6282524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Digitalis intoxication: specifity and significance of cardiac and extracardiac symptoms. part I: Patients with digitalis-induced arrhythmias (author's transl)].
    Doering W; König E; Sturm W
    Z Kardiol; 1977 Mar; 66(3):121-8. PubMed ID: 857452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of potassium canrenoate in the prevention of arrhythmia during the acute phase of myocardial infarction].
    Denis B; Machecourt J; Denis MC; Morena H; Pellet J; Rossignol B; Martin-Noël P
    Arch Mal Coeur Vaiss; 1979 Sep; 72(9):1014-22. PubMed ID: 116612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Experiences with cases of digitalis intoxication treated in the coronary unit].
    De Michelis S; Seu V; Abrile PG; Boero E; Rosselli P; Magaja O; Mocini A
    Clin Ter; 1979 Jun; 89(5):463-72. PubMed ID: 535323
    [No Abstract]   [Full Text] [Related]  

  • 15. Failure of potassium canrenoate to alter experimentally induced digitalis arrhythmias.
    Lucchesi BR; Haley NR
    Eur J Pharmacol; 1973 Jun; 22(3):256-62. PubMed ID: 4732564
    [No Abstract]   [Full Text] [Related]  

  • 16. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy.
    Andriulli A; Arrigoni A; Gindro T; Karbowiak I; Buzzetti G; Armanini D
    Digestion; 1989; 44(3):155-62. PubMed ID: 2697627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of patients with ventricular fibrillation during antiarrhythmic drug therapy.
    Minardo JD; Heger JJ; Miles WM; Zipes DP; Prystowsky EN
    N Engl J Med; 1988 Aug; 319(5):257-62. PubMed ID: 3393179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Digitalis intoxication in patients with atrial fibrillation.
    Kastor JA
    Circulation; 1973 Apr; 47(4):888-96. PubMed ID: 4572387
    [No Abstract]   [Full Text] [Related]  

  • 19. Patients with acute heart failure treated with the CARRESS-HF diuretic protocol in association with canrenoate potassium: Tolerance of high doses of canrenoate potassium.
    Berger C; Prieur C; Bochaton T; Berthiller J; Luyt CE; Bonnefoy-Cudraz E
    Arch Cardiovasc Dis; 2020 Nov; 113(11):679-689. PubMed ID: 32948466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical manifestations of elderly patients with digitalis intoxication in the emergency department.
    Pita-Fernández S; Lombardía-Cortiña M; Orozco-Veltran D; Gil-Guillén V
    Arch Gerontol Geriatr; 2011; 53(2):e106-10. PubMed ID: 20705347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.